These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32116860)

  • 1. Survey of Addiction Specialists' Use of Medications to Treat Alcohol Use Disorder.
    Ehrie J; Hartwell EE; Morris PE; Mark TL; Kranzler HR
    Front Psychiatry; 2020; 11():47. PubMed ID: 32116860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice Habits, Knowledge, and Attitudes of Hepatologists to Alcohol Use Disorder Medication: Sobering Gaps and Opportunities.
    Cotter TG; Ayoub F; King AC; Reddy KG; Charlton M
    Transplant Direct; 2020 Oct; 6(10):e603. PubMed ID: 33134483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey.
    Leung JG; Narayanan PP; Markota M; Miller NE; Philbrick KL; Burton MC; Kirchoff RW
    Front Psychiatry; 2022; 13():856938. PubMed ID: 35619618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
    Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' opinions about medications to treat alcoholism.
    Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
    Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.
    Williams EC; Achtmeyer CE; Young JP; Berger D; Curran G; Bradley KA; Richards J; Siegel MB; Ludman EJ; Lapham GT; Forehand M; Harris AHS
    J Gen Intern Med; 2018 Mar; 33(3):258-267. PubMed ID: 29086341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Ohio Advanced Practice Registered Nurses' Rate of Prescribing Naltrexone for Patients With Alcohol Use Disorder Since Elimination of the X-Waiver.
    Wiggins M; Smith A; Helsabeck N
    J Am Psychiatr Nurses Assoc; 2024 Aug; ():10783903241271273. PubMed ID: 39155585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group.
    Im GY; Mellinger JL; Winters A; Aby ES; Lominadze Z; Rice J; Lucey MR; Arab JP; Goel A; Jophlin LL; Sherman CB; Parker R; Chen PH; Devuni D; Sidhu S; Dunn W; Szabo G; Singal AK; Shah VH
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2407-2416.e8. PubMed ID: 33069880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel human laboratory model for screening medications for alcohol use disorder.
    Ho D; Towns B; Grodin EN; Ray LA
    Trials; 2020 Nov; 21(1):947. PubMed ID: 33225963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider perspectives on emergency department initiation of medication assisted treatment for alcohol use disorder.
    Philippine T; Forsgren E; DeWitt C; Carter I; McCollough M; Taira BR
    BMC Health Serv Res; 2022 Apr; 22(1):456. PubMed ID: 35392901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Survey of ASAM Members' Knowledge, Attitudes, and Practices in Urine Drug Testing.
    Kirsh KL; Baxter LE; Rzetelny A; Mazuk M; Passik SD
    J Addict Med; 2015; 9(5):399-404. PubMed ID: 26335003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for Alcohol Use Disorders: Physicians' Perceptions and Practices.
    Ponce Martinez C; Vakkalanka P; Ait-Daoud N
    Front Psychiatry; 2016; 7():182. PubMed ID: 27895598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.
    Wiercigroch D; Sheikh H; Hulme J
    Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):4. PubMed ID: 31931831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medications for Alcohol Use Disorder among Birthing People with an Alcohol-related Diagnosis.
    Roberts SC; Liu G; Terplan M
    J Addict Med; 2024 Sep; ():. PubMed ID: 39230045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.
    Hagedorn HJ; Wisdom JP; Gerould H; Pinsker E; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Harris AHS
    Addict Sci Clin Pract; 2019 Jul; 14(1):24. PubMed ID: 31291996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of alcohol addiction: current perspectives.
    Zastrozhin MS; Skryabin VY; Miroshkin SS; Bryun EA; Sychev DA
    Appl Clin Genet; 2019; 12():131-140. PubMed ID: 31372024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.